|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Abstract
Gonadal function is critically dependant on regulated
secretion of the gonadotropin hormones from anterior
pituitary gonadotroph cells. Gonadotropin biosynthesis
and release is triggered by the binding of hypothalamic
GnRH to GnRH receptor expressed on the gonadotroph cell
surface. The repertoire of regulatory molecules
involved in this process are still being defined. We
used the mouse L
T2 gonadotrope cell-line, which
expresses both gonadotropin hormones, as a model to
investigate GnRH regulation of gene expression and
differential display RT-PCR to identify and isolate
hormonally induced changes. This approach identified
Fanconi anemia A (FancA), a gene implicated in DNA
damage repair, as a differentially expressed
transcript. Mutations in FancA account for the majority
of cases of Fanconi anemia (FA), a recessively inherited
disease identified by congenital defects, bone marrow
failure, infertility and cancer susceptibility. We
confirmed expression and hormonal regulation of FancA
mRNA by quantitative RT-PCR, which showed that GnRH
induced a rapid, transient increase in FancA mRNA.
FancA protein was also acutely up regulated after GnRH
treatment of L
T2 cells. In addition, FancA gene
expression was confined to mature pituitary gonadotropes
and adult mouse pituitary and was not expressed in the
immature
T3-1 gonadotrope cell-line. Thus, this
study extends the expression profile of FancA into a highly
specialised endocrine cell, and demonstrates hormonal
regulation of expression of the FancA locus. We
suggest that this regulatory mechanism may have a crucial
role in the GnRH-response mechanism of mature gonadotropes
and perhaps the etiology of FA.
Key words:
Mechanisms of Hormone Action
Pituitary
Anterior pituitary
Gene regulation
Gonadotropin-releasing hormone
This article has been cited by other articles:
![]() |
J. P. Venables, R. Klinck, A. Bramard, L. Inkel, G. Dufresne-Martin, C. Koh, J. Gervais-Bird, E. Lapointe, U. Froehlich, M. Durand, et al. Identification of Alternative Splicing Markers for Breast Cancer Cancer Res., November 15, 2008; 68(22): 9525 - 9531. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Maudsley, Z. Naor, D. Bonfil, L. Davidson, D. Karali, A. J. Pawson, R. Larder, C. Pope, N. Nelson, R. P. Millar, et al. Proline-Rich Tyrosine Kinase 2 Mediates Gonadotropin-Releasing Hormone Signaling to a Specific Extracellularly Regulated Kinase-Sensitive Transcriptional Locus in the Luteinizing Hormone {beta}-Subunit Gene Mol. Endocrinol., May 1, 2007; 21(5): 1216 - 1233. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Larder, D. Karali, N. Nelson, and P. Brown Fanconi Anemia a Is a Nucleocytoplasmic Shuttling Molecule Required for Gonadotropin-Releasing Hormone (GnRH) Transduction of the GnRH Receptor Endocrinology, December 1, 2006; 147(12): 5676 - 5689. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |